Model-Informed Precision Dosing of Remimazolam in General Anesthesia Patients

Area of Science:

• Pharmacology
• Anesthesiology
• Computational modeling

Background:

• Remimazolam is an ultra-short-acting benzodiazepine used for general anesthesia.
• Understanding its pharmacokinetics/pharmacodynamics (PK/PD) is crucial for optimizing its clinical use.
• Population PK/PD modeling allows for characterizing drug behavior in diverse patient populations.

Purpose of the Study:

• To characterize the PK/PD of remimazolam in patients undergoing general anesthesia.
• To develop a user-friendly, web-based dashboard tool for determining optimal remimazolam dosing regimens.
• To establish a reliable tool for personalized anesthesia management.

Main Methods:

• Population PK/PD analysis of remimazolam in 20 patients receiving general anesthesia.
• Collection of intensive arterial blood samples and bispectral index (BIS) data.
• Development of a three-compartment PK model and an inhibitory sigmoid Emax PD model using RxODE and Shiny in R.

Main Results:

• A three-compartment model with first-order elimination accurately described remimazolam PK, with allometric scaling for weight adjustment.
• The relationship between remimazolam exposure and BIS was effectively modeled using an effect compartment and sigmoid Emax model.
• A web-based dashboard was created, providing personalized dosing strategies and PK/PD profile visualizations.

Conclusions:

• The population PK/PD model successfully characterized the dose-exposure-response relationship of remimazolam.
• The developed dashboard tool enables optimization of personalized dosing strategies for remimazolam in general anesthesia.
• This approach facilitates improved precision in anesthesia delivery and patient management.